血管平滑肌细胞增殖相关microRNA的研究进展
被引量:2
摘要
microRNAs(miRNAs)是1993年Ambro教授在研究线虫发育时序时最先发现的。miRNAs与其靶mRNA分子组成一个复杂的调控网络.参与机体发育、于细胞分化、心血管疾病、肿瘤、
出处
《实用医学杂志》
CAS
北大核心
2013年第21期3610-3612,共3页
The Journal of Practical Medicine
基金
国家自然科学基金资助项目(编号:81100211)
南华大学博士启动基金项目(编号:2012XQD27)
参考文献20
-
1Mendell J T, Olson E N. MicroRNAsin stress signaling and human disease[J]. Cell, 2012,148(6):1172-1187.
-
2Qin S, Zhang C. MicroRNAs in vascu-lar disease[J], J Cardiovasc Pharma-col, 2011,57(1):8-12.
-
3Virtue A, Mai J, Yin Y, et al. Struc-tural evidence of anti-atherogenic mi-croRNAs[J]. Front Biosci(LandmarkEd), 2011,16:3133-3145.
-
4Madrigal-Matute J, Hotllan N, ArandaJ F, et al. MicroRNAs and atheroscle-rosis[J]. Curr Atheroscler Rep,2013,15(5):322.
-
5Jakob P, Landmesser U. Role of mi-croRNAs in stem/progenitor cells andcardiovascular repair[J]. CardiovascRes, 2011,93(4):614-622.
-
6Cheng Y,Liu X, Yang J,et al. Mi-croRNA-145, a novel smooth musclecell phenotypic marker and modulator,controls vascular neointimal lesion for-mation[J]. Circ Res, 2009,105(2):158-166.
-
7Hergenreider E,Heydt S,Treguer K,et al. Atheroprotebtive communicationbetween endothelial cells and smoothmuscle cells through miRNAs[J]. NatCell Biol, 2012,14(3):249-256.
-
8Cordes K R, Sheehy N T,White MP, et al. miR-145 and miR-143 regu-late smooth muscle cell fate and plas-ticity[J]. Nature, 2009,460(7256):705-710.
-
9Boettger T,Beetz N, Kostin S,et al.Acquisition of the contractile phenotypeby murine arterial smooth muscle cellsdepends on the Mirl43/145 gene clus-ter[J]. J Clin Invest, 2009,119(9):2634-2647.
-
10Xin M, Small E M,Sutherland L B,et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamicsand responsiveness of smooth musclecells to injury[J]. Genes Dev,2009,23(18):2166-2178.
同被引文献27
-
1唐朝枢,齐永芬.关注血管钙化发病新机制的研究[J].中国医学前沿杂志(电子版),2010,2(3):5-8. 被引量:10
-
2Goettsch C, Rauner M, Pacyna N, et al. miR-125b regulates cal- cification of vascular smooth muscle cells [ J ]. Am J Pathol, 2011, 179(4) : 1594 - 1600.
-
3Wang H, Peng W, Ouyang X, et al. Reduced eirculating mi- R-15b is eorrelated with phosphate metabolism in patients with end-stage renal disease on maintenance hemodialysis [ J ]. Ren Fail, 2012, 34(6) : 685 -690.
-
4Du Y, Gao C, Liu Z, et al. Upregulation of a disintegrin and metalloproteinase with thronospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification [ J 1. Arterioscler Thromb Vase Biol, 2012, 32 ( 11 ) : 2580 - 2588.
-
5Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications [ J ]. Circ Res, 2006, 99(10): 1044- 1159.
-
6Pasquinelli AE, Ruvkun G. Control of developmental timing by micromas and their targets[ J]. Annu Rev Cell Dev Biol, 2002, 18:495 -513.
-
7Cui RR, Li SJ, Liu LJ, et al. MieroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo [ J ]. Cardiovasc Res, 2012, 96(2) : 320 -329.
-
8Qiao W, Chen L, Zhang M. MicroRNA-205 regulates the calcifi- cation and osteoblastie differentiation of vascular smooth muscle cells[J]. Cell Physiol Biochem, 2014, 33(6) : 1945 -1953.
-
9Mackenzie NC, Staines KA, Zhu D, et al. miRNA-221 and mi- RNA-222 synergistically function to promote vascular calcification [J]. Cell Biochem Funct, 2014, 32(2): 209-216.
-
10Rangrez AY, M' Baya-Moutoula E, Metzinger-Le Meuth V, et al. Inorganic phosphate accelerates the migration of vascular smooth muscle cells : evidence for the involvement of miR-223 [ J ]. PLoS One, 2012, 7(10) : e47807.
-
1周鸿,山杉公男.DHA对大白鼠血胆固醇浓度及磷脂分子组成的影响[J].江西科学,2003,21(2):95-100. 被引量:4
-
2傅明,马书林,毕燕芳,陈学伟,张龙泽.生物活性铬的研究进展[J].中国药学杂志,2004,39(10):732-734. 被引量:8
-
3维宣.神奇的分子——药物如何在我们身体里起作用[J].现代健康人,2004,7(8):40-41.
-
4安世民,丁旭苹,朱亮.非小细胞肺癌分子分型与信号调控网络[J].中国新药杂志,2015,24(24):2797-2802. 被引量:1
-
5于力.抗生素在儿科疾病中的应用[J].中国处方药,2003,2(9):72-75. 被引量:1
-
6陈超.新生儿常用药物治疗[J].世界临床药物,2004,25(6):341-345. 被引量:5
-
7黄淑芳,黄文海,胡永洲.多靶点阿尔茨海默症治疗药物的研究进展[J].中国药物化学杂志,2011,21(6):433-441. 被引量:2
-
8景新(摘).Eiigen输送技术用于肝素[J].国外药讯,2006(5):34-34.
-
9马明月,张玉敏,段志文,裴秀丛,张亭亭,罗金光.青春期前DEHP暴露对雌性大鼠机体发育及卵巢脂质过氧化的影响[J].沈阳医学院学报,2008,10(4):202-204. 被引量:8
-
10李艳.儿科用药不良反应37例报告分析[J].临床合理用药杂志,2012,5(35):3-3. 被引量:4